Shree Ganesh Remedies informs about announcement

27 May 2021 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shree Ganesh Remedies has informed that the company has successfully commissioned a new Plant No.3B at GIDC Ankleshwar, with an installed production capacity 54 KL (Kilo litres) working volumes for its existing products. The trial run of the plant was successfully completed on May 26, 2021 and the Company is expected to begin commercial production by early June, 2021. Further the commissioning of new Plant No.3B has been funded through internal accruals and the Company continues to be a 'Zero Debt Entity'.

The above information is a part of company’s filings submitted to BSE.

Shree Ganesh Remed. Share Price

441.55 11.70 (2.72%)
11-Dec-2025 11:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.00
Dr. Reddys Lab 1262.05
Cipla 1505.15
Zydus Lifesciences 924.30
Lupin 2070.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×